Polls

Would you be more open to prescribing a GLP-1 Inhibitor if there was an oral product rather than an injectable? Follow the link to share your opinion and see what your colleagues think.

How comfortable are you with prescribing a SGLT-2 inhibitor? Follow the link to see how you and your colleagues compare.

Should we lower the A1c to 5.7 for the diagnosis for diabetes and remove prediabetes as a diagnosis, so that we can treat pharmaceutically? Follow the link to share your opinion.

Would you be open to using a CGM for your type 2 patients who are not on insulin? Follow the link to share your response.

Which criteria other than fasting blood sugar do you feel is most important before providing an A1c test for your patients -- Weight, Family history, Hypertension, Age, Gender, Amount of physical activity? Follow the link to respond.

At what A1c do you feel comfortable using triple therapy for a patient with type 2 and excessive weight? 8%, 9%, 10%, or 11%? Follow the link to respond.

Which brand of Continuous Glucose Monitor (CGM) do you prefer -- Dexcom, Abbott FreeStyle Libre, or Eversense? Follow the link to respond.

Do you recommend a CGM for all your patients who are not achieving their target blood glucose and who are on insulin? Follow the link to respond.

Would you feel comfortable using a combination treatment of a GLP-1 receptor agonist and a SGLT-2 inhibitor for a patient who has not reached goal? Follow the link to respond.

Have you recommended to any patients the drug treatment of using a GLP-1 receptor agonist and a SGLT-2 inhibitor combination? Follow the link to share your opinion.